Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - emadine
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mpbf83463883d97743be055a0192c94a53
identifier: http://ema.europa.eu/identifier
/EU/1/98/095/001-2
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: EMADINE 0.5 mg/ml, eye drops, solution
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-bf83463883d97743be055a0192c94a53
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/98/095/001-2
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - emadine
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
EMADINE is a medicine for the treatment of seasonal allergic conjunctivitis of the eye (allergic conditions of the eye). It works by reducing the intensity of the allergic reaction.
Allergic conjunctivitis. Some materials (allergens) like pollens, house dust or animal fur may cause allergic reactions resulting in itching, redness as well as swelling of the surface of your eye.
You must talk to a doctor if you do not feel better or if you feel worse.
Do not use EMADINE
Warning and precautions
Talk to your doctor or pharmacist before using EMADINE.
Other medicines and EMADINE Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
If you are using other eye drops at the same time as EMADINE, follow the advice at the end of section 3 How to use EMADINE . Pregnancy, breast feeding and fertility If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines You may find that your vision is blurred for a time just after you use EMADINE. Do not drive or use machines until your vision is clear.
EMADINE contains benzalkonium chloride
This medicine contains 0.5 mg or 1 mg benzalkonium chloride in each 5 or 10 ml, which are equivalent to 0.1 mg/ml.
The preservative in EMADINE, benzalkonium chloride, may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards. Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.
Always use EMADINE exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The recommended dose is in adults and children over 3 years: One drop in the eye, twice a day.
Always use this medicine exactly as described in this leaflet or as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Only use the drops in your eyes.
Turn the page for more advice
Now turn over>
1 2
The recommended dose < see side 1
If you accidentally swallow EMADINE or inject it contact a doctor immediately. It may affect your heart rhythm.
If a drop misses your eye, try again.
If you get too much in your eyes, rinse it all out preferably with sterile saline or, if not available, with warm water. Don t put in any more drops until it s time for your next regular dose.
If you forget to use EMADINE, use one drop as soon as you remember, and then go back to your normal routine. Do not use a double dose to make up for the one missed.
If you are using other eye drops, leave at least 10 minutes between using EMADINE and the other drops. Eye ointments should be used last.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You can carry on taking the drops, unless the effects are serious, If you are worried, talk to your doctor or pharmacist.
Common side effects (may affect up to 1in 10 people )
Uncommon side effects (may affect up to 1 in 100 people)
Not Known (frequency cannot be estimated from the available data)
Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children. Do not use EMADINE after the expiry date which is stated on the bottle and box after EXP . The expiry date refers to the last day of the month.
Do not store above 25 C.
You must throw away the bottle four weeks after you first opened it, to prevent infections. Write down the date you opened each bottle in the space below and in the space on the bottle label and box.
Opened:
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Entry 1 - fullUrl = Composition/composition-en-bf83463883d97743be055a0192c94a53
Resource Composition:
Generated Narrative: Composition composition-en-bf83463883d97743be055a0192c94a53
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/98/095/001-2status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - emadine
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mpbf83463883d97743be055a0192c94a53
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mpbf83463883d97743be055a0192c94a53
identifier:
http://ema.europa.eu/identifier
/EU/1/98/095/001-2type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: EMADINE 0.5 mg/ml, eye drops, solution
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en